| Primary |
| Product Used For Unknown Indication |
80.0% |
| Insomnia |
12.6% |
| Depression |
6.3% |
| Sleep Study |
1.1% |
|
| Completed Suicide |
48.0% |
| Insomnia |
8.0% |
| Major Depression |
8.0% |
| Cardio-respiratory Arrest |
4.0% |
| Dyspnoea |
4.0% |
| Hallucination |
4.0% |
| Incoherent |
4.0% |
| Mental Status Changes |
4.0% |
| Psychotic Disorder |
4.0% |
| Reflux Oesophagitis |
4.0% |
| Type 1 Diabetes Mellitus |
4.0% |
| Vasospasm |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
48.9% |
| Drug Use For Unknown Indication |
27.4% |
| Insomnia |
4.3% |
| Suicide Attempt |
4.3% |
| Completed Suicide |
3.1% |
| Nightmare |
1.9% |
| Anxiety |
1.5% |
| Major Depression |
1.5% |
| Suicidal Ideation |
1.5% |
| Depression |
1.2% |
| Hallucination, Auditory |
1.2% |
| Metastatic Malignant Melanoma |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Bursitis |
0.4% |
| Psychotic Disorder |
0.3% |
| Ear Infection |
0.1% |
| Hormone Replacement Therapy |
0.1% |
| Initial Insomnia |
0.1% |
| Middle Insomnia |
0.1% |
|
| Completed Suicide |
39.0% |
| Respiratory Arrest |
16.5% |
| Toxicity To Various Agents |
7.5% |
| Poisoning |
4.5% |
| Weight Increased |
4.5% |
| Cardio-respiratory Arrest |
4.0% |
| Death |
4.0% |
| Thrombocytopenia |
4.0% |
| Cardiac Arrest |
2.0% |
| Drug Toxicity |
2.0% |
| Mental Status Changes |
2.0% |
| Sciatic Nerve Palsy |
2.0% |
| Incoherent |
1.5% |
| Intentional Drug Misuse |
1.5% |
| Psychotic Disorder |
1.5% |
| Middle Insomnia |
1.0% |
| Toxic Encephalopathy |
1.0% |
| Blood Bilirubin Increased |
0.5% |
| Blood Creatine Phosphokinase Increased |
0.5% |
| Cardiac Failure |
0.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.0% |
| Drug Use For Unknown Indication |
28.1% |
| Depression |
5.4% |
| Pain |
3.4% |
| Insomnia |
3.4% |
| Anxiety |
3.0% |
| Rheumatoid Arthritis |
2.6% |
| Hypertension |
2.6% |
| Crohn's Disease |
1.8% |
| Peritoneal Dialysis |
1.2% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Hepatitis C |
1.0% |
| Nausea |
1.0% |
| Sleep Disorder |
0.9% |
| Thrombosis Prophylaxis |
0.9% |
| Type 2 Diabetes Mellitus |
0.8% |
| Diffuse Large B-cell Lymphoma |
0.7% |
| Blood Pressure |
0.7% |
| Chest Pain |
0.7% |
| Mineral Supplementation |
0.7% |
|
| Vomiting |
20.5% |
| Encephalopathy |
8.4% |
| X-ray Abnormal |
7.2% |
| Pneumonia |
6.0% |
| Tremor |
6.0% |
| Weight Decreased |
4.8% |
| Wound Dehiscence |
4.8% |
| Delirium |
3.6% |
| Dyspnoea |
3.6% |
| Hypersensitivity |
3.6% |
| Pruritus |
3.6% |
| Pulmonary Embolism |
3.6% |
| Pyrexia |
3.6% |
| Tooth Extraction |
3.6% |
| Vein Disorder |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
| Adverse Drug Reaction |
2.4% |
| Asthenia |
2.4% |
| Cardio-respiratory Arrest |
2.4% |
| Cellulitis |
2.4% |
|
| Interacting |
| Pulmonary Arterial Hypertension |
100.0% |
|
|
